These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32050100)

  • 1. Intraperitoneal injection of ginkgolide B, a major active compound of Ginkgo biloba, dose-dependently increases the amount of wake and decreases non-rapid eye movement sleep in C57BL/6 mice.
    Nishimon S; Yamaguchi M; Muraki H; Sakai N; Nishino S
    Neurosci Lett; 2020 Mar; 722():134832. PubMed ID: 32050100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetic properties of Bilobalide and Ginkgolides A and B in healthy subjects after intravenous and oral administration of Ginkgo biloba extract (EGb 761)].
    Fourtillan JB; Brisson AM; Girault J; Ingrand I; Decourt JP; Drieu K; Jouenne P; Biber A
    Therapie; 1995; 50(2):137-44. PubMed ID: 7631288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological studies supporting the therapeutic use of Ginkgo biloba extract for Alzheimer's disease.
    Ahlemeyer B; Krieglstein J
    Pharmacopsychiatry; 2003 Jun; 36 Suppl 1():S8-14. PubMed ID: 13130383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of bilobalide, ginkgolide A and B after administration of three different Ginkgo biloba L. preparations in humans.
    Woelkart K; Feizlmayr E; Dittrich P; Beubler E; Pinl F; Suter A; Bauer R
    Phytother Res; 2010 Mar; 24(3):445-50. PubMed ID: 20041430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of single intraperitoneal injections of an extract of Ginkgo biloba (EGb 761) and its terpene trilactone constituents on barbital-induced narcosis in the mouse.
    Brochet D; Chermat R; DeFeudis FV; Drieu K
    Gen Pharmacol; 1999 Sep; 33(3):249-56. PubMed ID: 10480658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GABAA receptor cysteinyl mutants and the ginkgo terpenoid lactones bilobalide and ginkgolides.
    Ng CC; Duke RK; Hinton T; Johnston GA
    Eur J Pharmacol; 2016 Apr; 777():136-46. PubMed ID: 26953225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An anxiolytic-like effect of Ginkgo biloba extract and its constituent, ginkgolide-A, in mice.
    Kuribara H; Weintraub ST; Yoshihama T; Maruyama Y
    J Nat Prod; 2003 Oct; 66(10):1333-7. PubMed ID: 14575433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of ginkgolide A, B, and bilobalide in biloba L. extracts by microdialysis-HPLC.
    Chiu HL; Lin HY; Yang TC
    Anal Bioanal Chem; 2004 Jun; 379(3):445-8. PubMed ID: 15057504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ginkgo biloba extract attenuates warfarin-mediated anticoagulation through induction of hepatic cytochrome P450 enzymes by bilobalide in mice.
    Taki Y; Yokotani K; Yamada S; Shinozuka K; Kubota Y; Watanabe Y; Umegaki K
    Phytomedicine; 2012 Jan; 19(2):177-82. PubMed ID: 21802929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ginkgolide B on striatal extracellular amino acids in middle cerebral artery occluded rats.
    Yang ZZ; Li J; Li SX; Feng W; Wang H
    J Ethnopharmacol; 2011 Jun; 136(1):117-22. PubMed ID: 21527331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of food and gender on the pharmacokinetics of ginkgolides A, B, C and bilobalide in rats after oral dosing with ginkgo terpene lactones extract.
    Huang P; Zhang L; Chai C; Qian XC; Li W; Li JS; Di LQ; Cai BC
    J Pharm Biomed Anal; 2014 Nov; 100():138-144. PubMed ID: 25165009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of cytochrome P450 3A by the Ginkgo biloba extract and bilobalides in human and rat primary hepatocytes.
    Deng Y; Bi HC; Zhao LZ; Wang XD; Chen J; Ou ZM; Ding L; Xu LJ; Guan S; Chen X; Zhou SF; Huang M
    Drug Metab Lett; 2008 Jan; 2(1):60-6. PubMed ID: 19356072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct role of bilobalide and ginkgolide A in the modulation of rat CYP2B1 and CYP3A23 gene expression by Ginkgo biloba extract in cultured hepatocytes.
    Chang TK; Chen J; Teng XW
    Drug Metab Dispos; 2006 Feb; 34(2):234-42. PubMed ID: 16258077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidative activity of ginkgolides against superoxide in an aprotic environment.
    Scholtyssek H; Damerau W; Wessel R; Schimke I
    Chem Biol Interact; 1997 Oct; 106(3):183-90. PubMed ID: 9413545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary excretion of ginkgolide terpene lactones following acute consumption of Ginkgo biloba extract.
    Dew TP; Wang G; Williamson G
    Biofactors; 2014; 40(2):268-74. PubMed ID: 24255015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of bilobalide, ginkgolide B and picrotoxinin on GABA
    Ng CC; Duke RK; Hinton T; Johnston GAR
    Eur J Pharmacol; 2017 Jul; 806():83-90. PubMed ID: 28416372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of repeated treatments with an extract of Ginkgo biloba (EGb 761), bilobalide and ginkgolide B on the electrical activity of pancreatic beta cells of normal or alloxan-diabetic mice: an ex vivo study with intracellular microelectrodes.
    Vasseur M; Jean T; DeFeudis FV; Drieu K
    Gen Pharmacol; 1994 Jan; 25(1):31-46. PubMed ID: 8026711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability of ginkgolides and bilobalide from extracts of ginkgo biloba using GC/MS.
    Biber A; Koch E
    Planta Med; 1999 Mar; 65(2):192-3. PubMed ID: 10193211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of organic anion transporter 1/3 on the pharmacokinetics and renal excretion of ginkgolides and bilobalide.
    Yaro P; Nie J; Xu M; Zeng K; He H; Yao J; Wang R; Zeng S
    J Ethnopharmacol; 2019 Oct; 243():112098. PubMed ID: 31325605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity studies with Ginkgo biloba extract constituents as receptor-gated chloride channel blockers and modulators.
    Chatterjee SS; Kondratskaya EL; Krishtal OA
    Pharmacopsychiatry; 2003 Jun; 36 Suppl 1():S68-77. PubMed ID: 13130392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.